Cas:959246-33-4 O-(1,3-benzothiazol-2-yl) (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoethanethioate manufacturer & supplier

Chemical Name:O-(1,3-benzothiazol-2-yl) (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoethanethioate

CAS.NO:959246-33-4

Synonyms:(Benzothiazol-2-yl)-2-(2-Aminothiazol-4-yl)-(Z)-2-Methoxyimino Thioacetate

Molecular Formula:C₁₃H₁₀N₄O₂S₃

Molecular Weight:350.43900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:171.92000

Exact Mass:349.99700

LogP:3.02200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (Benzothiazol-2-yl)-2-(2-Aminothiazol-4-yl)-(Z)-2-Methoxyimino Thioacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(Benzothiazol-2-yl)-2-(2-Aminothiazol-4-yl)-(Z)-2-Methoxyimino Thioacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(Benzothiazol-2-yl)-2-(2-Aminothiazol-4-yl)-(Z)-2-Methoxyimino Thioacetate Use and application,(Benzothiazol-2-yl)-2-(2-Aminothiazol-4-yl)-(Z)-2-Methoxyimino Thioacetate technical grade,usp/ep/jp grade.

Related News: Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility. A name could not be generated for this structure. manufacturers Founded outside Venice in 1949 as a maker of glass bottles for wine and perfume, the firm shifted to glass packaging for the pharmaceutical sector in the early 1970s and later grew to become a leading player in the industry, expanding overseas with new factories in Mexico in 2007 and China in 2012. Diphosphoric acid, tetrakis[2-[2-(2-methoxyethoxy)ethoxy]ethyl] ester suppliers In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April. D-glucopyransoe vendor & factory Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D.,The UK government has set out plans to make the UK the best destination in the world for researchers, making sure that it continues to attract the brightest and best from the UK and from overseas, cementing its status as a science superpower.